$ATVK
Ameritek Ventures, Inc.

2024 Q4 Form 10-Q Financial Statement

#000137647424000696 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $275.5K
YoY Change 47.83%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $97.80K
YoY Change -7.34%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $142.3K
YoY Change -24.05%
Operating Profit $133.1K
YoY Change -12767.17%
Interest Expense $45.97K
YoY Change 21.91%
% of Operating Profit 34.53%
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings $87.17K
YoY Change -324.91%
Net Earnings / Revenue 31.64%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 554.2M shares 554.2M shares
Diluted Shares Outstanding 613.2M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $2.336K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $1.519K
Receivables $141.2K
Other Receivables
Total Short-Term Assets $145.1K
YoY Change 72.78%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00
YoY Change
Goodwill $2.185M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $494.0K
YoY Change -7.52%
Total Long-Term Assets $3.620M
YoY Change -0.29%
TOTAL ASSETS
Total Short-Term Assets $145.1K
Total Long-Term Assets $3.620M
Total Assets $3.765M
YoY Change 1.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $692.3K
YoY Change -40.64%
Accrued Expenses $575.2K
YoY Change 180.2%
Deferred Revenue
YoY Change
Short-Term Debt $21.00K
YoY Change 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.849M
YoY Change -3.18%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.849M
Total Long-Term Liabilities
Total Liabilities $3.451M
YoY Change -1.37%
SHAREHOLDERS EQUITY
Retained Earnings -$2.276M
YoY Change -5.28%
Common Stock $613.2K
YoY Change 19.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$314.2K
YoY Change
Total Liabilities & Shareholders Equity $3.765M
YoY Change 1.36%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $87.17K
YoY Change -324.91%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Central Index Key
EntityCentralIndexKey
0001530185
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54739
dei Entity Registrant Name
EntityRegistrantName
Ameritek Ventures, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-2380777
dei Entity Address Address Line1
EntityAddressAddressLine1
325 N Milwaukee Ave. Suite G1
dei Entity Address City Or Town
EntityAddressCityOrTown
Wheeling
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60090
dei Entity Address Address Description
EntityAddressAddressDescription
Address of principal executive offices
dei City Area Code
CityAreaCode
312
dei Local Phone Number
LocalPhoneNumber
239-3574
dei Phone Fax Number Description
PhoneFaxNumberDescription
Issuer’s telephone number
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
554226791 shares
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.001
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2336 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5618 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
141214 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
132380 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1519 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1519 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
145069 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
139517 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2024Q3 us-gaap Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums
UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums
29568 usd
CY2023Q4 us-gaap Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums
UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums
35112 usd
CY2024Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
661886 usd
CY2023Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
661886 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
250000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
250000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
493982 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
524117 usd
CY2024Q3 us-gaap Goodwill
Goodwill
2184715 usd
CY2023Q4 us-gaap Goodwill
Goodwill
2184715 usd
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
3620151 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
3655830 usd
CY2024Q3 us-gaap Assets
Assets
3765220 usd
CY2023Q4 us-gaap Assets
Assets
3795347 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
692320 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
987071 usd
CY2024Q3 us-gaap Loans Payable Current
LoansPayableCurrent
317793 usd
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
0 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
575172 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
547204 usd
CY2024Q3 us-gaap Deferred Revenue
DeferredRevenue
242546 usd
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
151005 usd
CY2024Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
21000 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
21000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1848831 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1706280 usd
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
1602239 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1933448 usd
CY2024Q3 us-gaap Liabilities
Liabilities
3451070 usd
CY2023Q4 us-gaap Liabilities
Liabilities
3639728 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
613226791 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
613226791 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
554226791 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
554226791 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
613227 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
554227 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
881317 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
885038 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2276007 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2379259 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-314150 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
155619 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3765220 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3795347 usd
CY2024Q3 us-gaap Revenues
Revenues
275458 usd
CY2023Q3 us-gaap Revenues
Revenues
186337 usd
us-gaap Revenues
Revenues
678300 usd
us-gaap Revenues
Revenues
702936 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
97797 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
105548 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
294434 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
406640 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34484 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
71796 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
115382 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
193584 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10045 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10044 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
30135 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
72593 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
142326 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
187388 usd
us-gaap Operating Expenses
OperatingExpenses
439951 usd
us-gaap Operating Expenses
OperatingExpenses
672817 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
133132 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1051 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
238349 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
30119 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
45967 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
37705 usd
us-gaap Interest Expense
InterestExpense
135097 usd
us-gaap Interest Expense
InterestExpense
112715 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
87167 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-38756 usd
us-gaap Net Income Loss
NetIncomeLoss
103252 usd
us-gaap Net Income Loss
NetIncomeLoss
-82596 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
613226791 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
514226791 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
613226791 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
514226791 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
613226791 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
514226791 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
613226791 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
514226791 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
298369 usd
us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-82596 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
215773 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
155619 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
55280 usd
us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
103252 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
314151 usd
us-gaap Profit Loss
ProfitLoss
103252 usd
us-gaap Profit Loss
ProfitLoss
-82596 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30135 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
72591 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
5544 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8834 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-299060 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-294751 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-24730 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
81697 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
90158 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
91541 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-181226 usd
us-gaap Increase Decrease In Other Loans
IncreaseDecreaseInOtherLoans
-317793 usd
us-gaap Increase Decrease In Other Loans
IncreaseDecreaseInOtherLoans
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
326377 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
173259 usd
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
0 usd
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-296155 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
28313 usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
33504 usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
194826 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-329659 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-166513 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3282 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6746 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5618 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
751 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2336 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7497 usd
us-gaap Interest Paid
InterestPaid
39321 usd
us-gaap Interest Paid
InterestPaid
19286 usd
us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
0 usd
us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
0 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font:9pt Times New Roman;margin-top:0pt;margin-bottom:10pt;margin-left:18pt"><kbd style="position:absolute;font:9pt Times New Roman;margin-left:-18pt"><b>1.</b></kbd><b>GENERAL ORGANIZATION AND BUSINESS</b> </p> <p style="font:9pt Times New Roman;margin:0;text-align:justify">The Company was organized on December 27, 2010, under the laws of the State of Nevada, as ATVROCKN. On June 20, 2017, the Company changed its corporate name to Ameritek Ventures, Inc (“Ameritek Ventures” or “Ameritek” or the “Company”).</p> <p style="font:9pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:9pt Times New Roman;margin:0;text-align:justify">Ameritek is a group of companies that provides various world-class software and hardware products and services beneficial to businesses, organizations, and governments. We have an established presence in the warehouse solutions market. With Interactive Systems, Inc. we provide software inventory management and with interlinkONE, Inc. we provide SaaS cloud-based solutions for warehouse and inventory fulfillment. We manufacture and innovate advanced technological developments in the medical industry, such as the DittoMask high-filtration mask. We also develop blockchain technology software programs under WebBeeO and CordTell companies. Furthermore, Ameritek Ventures explores augmented reality technology with Augmum, Inc. Meanwhile, our vertical landing aircraft service from AeroPass, Inc. takes ZenaDrone technology to a higher level with members-only passenger first-class transport across cities. Ecker Capital, LLC is our merger and acquisition division. ESM Software, Inc. is a software technology provider specializing in developing business strategy management solutions. The Company also recently created a new business, Equock, Inc., with which Ameritek will develop an electric bicycle with a focus on the growing online delivery industry.</p>
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2010-12-27
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
us-gaap Use Of Estimates
UseOfEstimates
<p style="font:9pt Times New Roman;margin:0;text-align:justify"><b>Use of Estimates</b></p> <p style="font:9pt Times New Roman;margin:0;text-align:justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2024Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
7694 usd
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
7694 usd
CY2024Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
28568 usd
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
28568 usd
CY2024Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4200 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4200 usd
CY2024Q3 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
2783 usd
CY2023Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
2783 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
43245 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
43245 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
43245 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
43245 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
43245 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
43245 usd
CY2023Q4 fil Product Development Costs
ProductDevelopmentCosts
602722 usd
fil Product Development Addition
ProductDevelopmentAddition
0 usd
CY2024Q3 fil Product Development Costs
ProductDevelopmentCosts
602722 usd
CY2023Q4 fil Product Development Total Amortizatiion
ProductDevelopmentTotalAmortizatiion
78605 usd
fil Product Development Amortization
ProductDevelopmentAmortization
10045 usd
CY2024Q3 fil Product Development Total Amortizatiion
ProductDevelopmentTotalAmortizatiion
30136 usd
CY2024Q3 fil Product Development Net Book Value
ProductDevelopmentNetBookValue
493981 usd
CY2022Q4 fil Goodwill Total Cost
GoodwillTotalCost
3150159 usd
CY2023 fil Transfer To Goodwill Cost
TransferToGoodwillCost
2184715 usd
CY2023Q4 fil Goodwill Total Cost
GoodwillTotalCost
965444 usd
CY2022Q4 fil Goodwill Book Value
GoodwillBookValue
2791472 usd
CY2022Q4 fil Goodwill Amortization
GoodwillAmortization
358687 usd
CY2023 fil Transfer To Goodwill Book Value
TransferToGoodwillBookValue
2184716 usd
CY2023 fil Goodwill Book Value Amortization
GoodwillBookValueAmortization
82637 usd
CY2023Q4 fil Goodwill Amortization
GoodwillAmortization
441324 usd
CY2023Q4 fil Goodwill Book Value
GoodwillBookValue
524119 usd
us-gaap Debt Instrument Issuer
DebtInstrumentIssuer
Ameritek
CY2024Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
185000 usd
us-gaap Debt Instrument Description
DebtInstrumentDescription
non-convertible promissory note
us-gaap Debt Instrument Issuance Date1
DebtInstrumentIssuanceDate1
2021-05-13
CY2024Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.15 pure
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
4727 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
24596 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
3596 usd
CY2024Q3 fil Promissory Notes Current
PromissoryNotesCurrent
0 usd
CY2023Q4 fil Promissory Notes Current
PromissoryNotesCurrent
0 usd
CY2024Q3 fil Promissory Notes Non Current
PromissoryNotesNonCurrent
1602239 usd
CY2023Q4 fil Promissory Notes Non Current
PromissoryNotesNonCurrent
1933448 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
613226791 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
554226791 shares
CY2023Q3 fil Accounts Payable Balance
AccountsPayableBalance
1158694 usd
CY2023Q3 fil Accounts Payable Balance Net
AccountsPayableBalanceNet
816314 usd
us-gaap Loss Contingency Actions Taken By Plaintiff
LossContingencyActionsTakenByPlaintiff
Meridian Pacific Holdings, LLC filed a lawsuit against certain directors, officers, affiliates, and the Company for breach of contract and fraud
us-gaap Loss Contingency Name Of Plaintiff
LossContingencyNameOfPlaintiff
Meridian Pacific Holdings, LLC
us-gaap Loss Contingency Allegations
LossContingencyAllegations
breach of contract and fraud
fil Loss Contingency Domicile Of Litigation1
LossContingencyDomicileOfLitigation1
Superior Court of the State of California, County of Los Angeles
fil Loss Contingency Lawsuit Filing Date2
LossContingencyLawsuitFilingDate2
May 6, 2024
us-gaap Gain Contingency Description
GainContingencyDescription
The Company filed a lawsuit in the Clark County, Nevada, court against Clinton L. Stokes, III, the former owner of the Company, to settle the matter of shares ownership
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
0 usd

Files In Submission

Name View Source Status
atvk-20240930_cal.xml Edgar Link unprocessable
0001376474-24-000696-index-headers.html Edgar Link pending
0001376474-24-000696-index.html Edgar Link pending
0001376474-24-000696.txt Edgar Link pending
0001376474-24-000696-xbrl.zip Edgar Link pending
atvk-20240930.htm Edgar Link pending
atvk-20240930.xsd Edgar Link pending
av_ex31z1.htm Edgar Link pending
av_ex31z2.htm Edgar Link pending
av_ex32z1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
atvk-20240930_def.xml Edgar Link unprocessable
atvk-20240930_lab.xml Edgar Link unprocessable
atvk-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
atvk-20240930_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending